The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening.

Bernhardt, Isaac; Glamuzina, Emma; Ryder, Bryony; Knoll, Detlef; Heather, Natasha; De Hora, Mark; Webster, Dianne; Wilson, Callum

Bernhardt, Isaac; Glamuzina, Emma; Ryder, Bryony; Knoll, Detlef; Heather, Natasha; De Hora, Mark; Webster, Dianne; Wilson, Callum.

Afiliação

Bernhardt I; National Metabolic Service, Auckland City Hospital and Starship Children's Hospital Auckland New Zealand.
Glamuzina E; National Metabolic Service, Auckland City Hospital and Starship Children's Hospital Auckland New Zealand.
Ryder B; National Metabolic Service, Auckland City Hospital and Starship Children's Hospital Auckland New Zealand.
Knoll D; Chemical Pathology (Section New Born Screening), Auckland City Hospital Auckland New Zealand.
Heather N; Newborn Metabolic Screening Unit, Auckland City Hospital Auckland New Zealand.
De Hora M; Chemical Pathology (Section New Born Screening), Auckland City Hospital Auckland New Zealand.
Webster D; Newborn Metabolic Screening Unit, Auckland City Hospital Auckland New Zealand.
Wilson C; National Metabolic Service, Auckland City Hospital and Starship Children's Hospital Auckland New Zealand.

JIMD Rep ; 64(2): 180-186, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36873086

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google